Venous Thromboembolism and Bariatric Surgery in the Middle East Region
Ashraf Haddad, Ahmad Bashir, Mohamed Al Hadad, Hayssam Fawal and Abdelrahman Nimeri
Article Type: Original Research | First Published: January 12, 2019
Eighty-two surgeons (63%) responded, they performed 121,369 cases and encountered 230 VTEs (0.19%). VTEs included 13 upper extremity, 103 lower extremity, 57 pulmonary embolism (PE), and 57 porto-mesenteric venous thrombosis (PMT). There was 9 VTE related mortalities constituting 4% mortality rate. The most commonly performed procedure was Sleeve Gastrostomy (56%). It was followed by Adjustable Gastric band (13%), One Anastomosis Gastric Bypass (10%), and Roux-en-Y Gastric bypass (9%). A scoring...
Idiopathic Colitis after Bilio-Pancreatic Diversion: A Report of Two Cases and a Review of the Literature
Forat Swaid, Mustafa Somri, Simona Croitoru and Ibrahim Matter
Article Type: Case Report | First Published: January 10, 2019
Biliopancreatic diversion (BPD) is considered the most effective procedure for the surgical treatment of morbid obesity. First presented by Dr. Nicola Scopinaro in 1976, this operation proved safe and reproducible, with astonishing results regarding weight loss and weight maintenance for many years after the operation. Possible late complications include anemia, stomal ulcer, bone demineralization, neurologic complications, and protein malnutrition....
Approach to Obesity Management in the Primary Care Setting
Samuel N Grief and Megan Waterman
Article Type: Research Article | First Published: January 09, 2019
Obesity is a complex, multifactorial disease that develops from the interaction between genotype and the environment. Our understanding of how and why obesity occurs is incomplete; however, it involves the integration of social, behavioral, cultural, physiological, metabolic, and genetic factors. Genetics has been a common variable researched among scientists, and the link has been proven between genetic predisposition and likelihood of developing obesity....
Monosodium Glutamate Affects Metabolic Syndrome Risk Factors on Obese Adult Rats: A Preliminary Study
Maria Catalina Olguin, Marta Delia Posadas, Gilda Celina Revelant, Dario Marinozzi, Veronica Labourdette and María Rosa Venezia
Article Type: Research Article | First Published: November 19, 2018
Monosodium glutamate (MSG) is one of the most widely employed food taste enhancers and there is a safety concern on glutamate with respect to the obesity epidemics. The reported effects are attributed to the actions of MSG in the brain, which would affect food intake, body weight and lipid metabolism. The aim of this study was to evaluate the effects of the addition of MSG to the rat chow on body weight, food intake, plasma glucose and aminotransferases and plasma and liver lipids in adult obese...
Weight Perceptions and Weight-Related Behaviors among Low Income Postpartum Women
Valerie J Silfee, Christina F Haughton, Nisha Kini, Stephenie C Lemon and Milagros C Rosal
Article Type: Original Research | First Published: November 17, 2018
Minority and low-income women have higher rates of postpartum weight retention, contributing to increased rates of obesity in these populations. Weight perceptions may be an important factor contributing to the adoption of weight-management behaviors. The purpose of this study was to examine the relationships between weight perceptions and weight-related behaviors among overweight low-income women during postpartum enrolled in a weight loss intervention study....
Microalbuminuria among Newly Diagnosed Diabetic Patients at Mulago National Referral Hospital in Uganda: A Cross Sectional Study
Muddu Martin, Mutebi Edrisa, Isaac SSinabulya, Kizito Samuel, Mulindwa Frank and Mondo Charles Kiiza
Article Type: Original Research Article | First Published: August 23, 2018
Microalbuminuria is an early marker of nephropathy, cardiovascular diseases and severe ocular morbidity in adults with diabetes mellitus. This subclinical condition is associated with high morbidity and mortality. Microalbuminuria precedes the development of overt diabetic nephropathy by 10-14 years. At this stage, one can reverse diabetic nephropathy or prevent its progression. Unfortunately, tests to detect microalbuminuria in diabetics are not routinely done in Uganda. This study sought to de...